Trials / Withdrawn
WithdrawnNCT04758260
Influence of the Antioxidant Treatment in the Oxidant-reduction Potential in Seminal Plasma in Men Whose Partners Will Undergo Through an Egg Donation Cycle
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- IVI Bilbao · Academic / Other
- Sex
- Male
- Age
- 18 Years – 48 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the influence of antioxidant men supplements treatment (Fertybiotic Hombre) in the rate of sORP (stactic Oxidation Reduction Potential) defined as the balanced measure between the total oxidant activity (ROS, superoxides, nitric oxide, peroxide) and total reducing activity (alpha tocopherol, β carotene, uric acid) in sperm samples during egg donation cycles. We will also evaluate the influence of the sORP rate in the embryo development during the egg donation treatments; taking in account the fecundation rate, percentage of blastocyst stage arrival embryos, number of frozen embryos, implantation rate, on-going pregnancy rate and miscarriage rate. The sperm sample will be measured by electrochemical technology using Mioxsys system for a quantitative measurement in millivolts (mV), in those male patients who participate in an egg donation assisted reproduction treatment. After 14 days, the pregnancy stage will be available. This information will be obtained from the patient's clinical history using the human chorionic gonadotropin hormone (shCG) in blood. It will be performed either in our Clinic or externally within the usual practice derived from the treatment carried out. These values will be compared with the results obtained from sORP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Antioxidant | Oral antioxidant oral intake in the 3 months prior to inclusion in the study |
Timeline
- Start date
- 2019-02-12
- Primary completion
- 2019-07-18
- Completion
- 2021-02-12
- First posted
- 2021-02-17
- Last updated
- 2021-02-17
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04758260. Inclusion in this directory is not an endorsement.